medRxiv 预印本· Ghosh, A., Ghosh, A., Sinha, A., Mathai, S., Bhaumik, J., Mukhopadhyay, A., Majumder, S., Maitra, A., Biswas, N. K., Mondal, K., Majumder, P. P., Sengupta, S. ·· 20 天前AI 评分28
研究揭示印度东部HPV16阳性宫颈癌中PIK3CA突变亚型的基因组与免疫特征
Integrated Genomic and Immune Profiling Reveals PIK3CA-Mutant HPV16-Positive Cervical Cancer as a Clinically Aggressive and Immunologically Distinct Subtype in Patients from Eastern India
AI 导读
对49例HPV16阳性宫颈肿瘤的全外显子测序显示,PIK3CA是最常见突变基因(42%),显著高于TCGA-CESC中HPV16阳性肿瘤的26.21%(p<0.04)。印度PIK3CA突变肿瘤多属晚期,病毒载量更低、肿瘤突变负荷更高,且PD-1/PD-L1转录偶联与CCL3-CCR1轴激活仅见于该亚型,提示免疫抑制微环境。
来源:medRxiv 预印本 · medrxiv.org